Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 Monotherapy to Methotrexate (MTX) in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response to MTX
Principal Investigator (?)
Study Number
F16020
Summary
This is a randomized, double-blind study comparing Upadacitinib (ABT-494) monotherapy to Methotrexate (MTX) monotherapy in subjects with moderately to severely active rheumatoid arthritis who have had an inadequate response to methotrexate treatment. 
Phase (?)
Phase III
Sponsor (?)
Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0